Sequence-structure functional implications and molecular simulation of high deleterious nonsynonymous substitutions in IDH1 revealed the mechanism of drug resistance in glioma

Sequence-structure functional implications and molecular simulation of high deleterious nonsynonymous substitutions in IDH1 revealed the mechanism of drug resistance in glioma

In the past few years, various somatic point mutations of isocitrate dehydrogenase (IDH) encoding genes (IDH1 and IDH2) have been identified in a broad range of cancers, including glioma. Despite the important function of IDH1 in tumorigenesis and its very polymorphic nature, it is not yet clear how...

Full description

Bibliographic Details
Main Authors:	Muhammad Suleman, Syeda Umme-I-Hani, Muhammad Salman, Mohammed Aljuaid, Abbas Khan, Arshad Iqbal, Zahid Hussain, Syed Shujait Ali, Liaqat Ali, Hassan Sher, Yasir Waheed, Dong-Qing Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Pharmacology
Subjects:	nsSNPs IDH1 molecular docking simulation binding free energy introduction
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.927570/full

Similar Items

Prediction of the most deleterious non-synonymous SNPs in the human IL1B gene: evidence from bioinformatics analyses
by: Ola Abuzaid, et al.
Published: (2024-06-01)

Exploring the impact of deleterious missense nonsynonymous single nucleotide polymorphisms in the DRD4 gene using computational approaches
by: Dipto Kumer Sarker, et al.
Published: (2025-01-01)

A comprehensive in silico analysis of structural and functional impacts of natural nonsynonymous SNPs in the ALDH2_HUMAN gene
by: Mehr Ali Mahmood Janlou
Published: (2025-01-01)

Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study
by: Muhammad Suleman, et al.
Published: (2021-06-01)

The investigation of nonsynonymous SNPs of human SLC6A4 gene associated with depression: An in silico approach
by: Md. Amit Hasan, et al.
Published: (2021-08-01)

Computational and Mass Spectrometry-Based Approach Identify Deleterious Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) in JMJD6
by: Tianqi Gong, et al.
Published: (2021-07-01)

Predicting Deleterious Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) of <i>HRAS</i> Gene and In Silico Evaluation of Their Structural and Functional Consequences towards Diagnosis and Prognosis of Cancer
by: Chuan-Yu Chai, et al.
Published: (2022-11-01)

Integrative genomic analyses combined with molecular dynamics simulations reveal the impact of deleterious mutations of Bcl-2 gene on the apoptotic machinery and implications in carcinogenesis
by: Ghazi Elamin, et al.
Published: (2025-01-01)

Erratum: Integrative genomic analyses combined with molecular dynamics simulations reveal the impact of deleterious mutations of Bcl-2 gene on the apoptotic machinery and implications in carcinogenesis
by: Frontiers Production Office
Published: (2025-01-01)

Pathogenic nsSNPs of protein kinase C-eta with hepatocellular carcinoma susceptibility
by: Tayyaba Hussain, et al.
Published: (2024-10-01)

Investigating the structural and functional consequences of germline single nucleotide polymorphisms located in the genes of the alternative lengthening of telomere (ALT) pathway
by: Nurun Nahar Nila, et al.
Published: (2024-06-01)

Transcription-translation error: In-silico investigation of the structural and functional impact of deleterious single nucleotide polymorphisms in GULP1 gene
by: Opeyemi S. Soremekun, et al.
Published: (2021-01-01)

Identification and analysis of oncogenic non-synonymous single nucleotide polymorphisms in the human NRAS gene: An exclusive in silico study
by: Md. Mozibullah, et al.
Published: (2024-06-01)

Analysis of damaging non-synonymous SNPs in GPx1 gene associated with the progression of diverse cancers through a comprehensive in silico approach
by: Muhammad Waleed Iqbal, et al.
Published: (2024-11-01)

Integration of association and computational methods reveals functional variants of LEPR gene for abdominal fat content in chickens
by: Yu-dong LI, et al.
Published: (2021-10-01)

Computational analysis uncovers the deleterious SNPs along with the mutational spectrum of p53 gene and its differential expression pattern in pan-cancer
by: Saruar Alam, et al.
Published: (2022-07-01)

In silico analysis revealed high-risk single nucleotide polymorphisms in human pentraxin-3 gene and their impact on innate immune response against microbial pathogens
by: Raman eThakur, et al.
Published: (2016-02-01)

Comprehensive Characterization of the Coding and Non-Coding Single Nucleotide Polymorphisms in the Tumor Protein p63 (TP63) Gene Using In Silico Tools
by: Shamima Akter, et al.
Published: (2021-11-01)

Computational and molecular insights on non-synonymous SNPs associated with human RAAS genes: Consequences for Hypertension vulnerability
by: Jeyanthi Sankar, et al.
Published: (2025-03-01)

Do environmentally induced DNA variations mediate adaptation in Aspergillus flavus exposed to chromium stress in tannery sludge?
by: Akanksha Jaiswar, et al.
Published: (2018-12-01)

SNP Analysis of the SOD1 gene involved in Amyotrophic Lateral Sclerosis (ALS)
by: Hetal Patel, et al.
Published: (2025-12-01)

Unraveling the structural and functional consequences of non-synonymous single-nucleotide polymorphisms (nsSNPs) in human SOCS2: an in silico approach
by: Tanvir Hossain, et al.
Published: (2025-02-01)

In Silico Evaluation of Coding and Non-Coding nsSNPs in the Thrombopoietin Receptor (<i>MPL</i>) Proto-Oncogene: Assessing Their Influence on Protein Stability, Structure, and Function
by: Hakeemah H. Al-nakhle, et al.
Published: (2023-11-01)

Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations
by: Savas Sevtap, et al.
Published: (2006-03-01)

In-silico analysis of CYP1A2 (cytochrome P450 1A2) missense mutations: Implications for pharmacogenetics
by: Yasamin Khiabani, et al.
Published: (2025-03-01)

Identification of deleterious non-synonymous single nucleotide polymorphisms in the mRNA decay activator ZFP36L2
by: Betül Akçeşme, et al.
Published: (2025-12-01)

Comprehensive In Silico Characterization of the Coding and Non-Coding SNPs in Human <i>Dectin-1</i> Gene with the Potential of High-Risk Pathogenicity Associated with Fungal Infections
by: Hakeemah H. Al-nakhle, et al.
Published: (2023-05-01)

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
by: Mathieu Simonin, et al.
Published: (2021-05-01)

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
by: Mohamed E. Elnageeb, et al.
Published: (2023-09-01)

Molecular Dynamics Simulation of Kir6.2 Variants Reveals Potential Association with Diabetes Mellitus
by: Mohamed E. Elangeeb, et al.
Published: (2024-04-01)

Correlations of MGMT promoter methylation and IDH1 mutations with the clinical prognosis of malignant glioma patients
by: ZHANG Ning, MA Hui-hui, WANG Fan, LIANG Wei, WANG Yi-chun, WU Bing-shan, LI Qing-xin
Published: (2021-10-01)

IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
by: Erika F. Rodriguez, et al.
Published: (2020-06-01)

Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, IDH1-mutant glioblastoma: a case report from a Phase I study
by: Dalissa Tejera, et al.
Published: (2020-09-01)

Implications of Concurrent <i>IDH1</i> and <i>IDH2</i> Mutations on Survival in Glioma—A Case Report and Systematic Review
by: Alexander Yuile, et al.
Published: (2022-10-01)

Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples
by: James P. Solomon, et al.
Published: (2024-05-01)

Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin
by: Tingting Yang, et al.
Published: (2020-06-01)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
by: Arne Christians, et al.
Published: (2019-10-01)

Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence
by: Abbas Khan, et al.
Published: (2022-09-01)

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
by: Lidia Gatto, et al.
Published: (2024-01-01)

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
by: Yu-Qing Liu, et al.
Published: (2019-12-01)